|
44 Companies |
|
73 Products |
|
73 Products |
|
66 Mechanisms of Action |
|
11 Trials |
|
2460 News |
|
| 12345678910111213...4950» |
- || Trial completion date, Trial primary completion date: TAVI/LAAO: Comparison of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients in AF Undergoing TAVI (clinicaltrials.gov) - May 8, 2024
P=N/A, N=80, Active, not recruiting, Sponsor: University of Zurich
Trial completion date: Feb 2024 --> Sep 2024 | Trial primary completion date: Jun 2023 --> Sep 2024
- | Trial completion date: TAVI/LAAO: Comparison of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients in AF Undergoing TAVI (clinicaltrials.gov) - Dec 5, 2023
P=N/A, N=80, Active, not recruiting, Sponsor: University of Zurich
Trial completion date: Feb 2024 --> Sep 2024 | Trial primary completion date: Jun 2023 --> Sep 2024 Trial completion date: Aug 2023 --> Feb 2024
- || Trial completion date, Trial primary completion date: TAVI/LAAO: Comparison of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients in AF Undergoing TAVI (clinicaltrials.gov) - Aug 1, 2023
P=N/A, N=80, Active, not recruiting, Sponsor: University of Zurich
Trial completion date: Aug 2023 --> Feb 2024 Trial completion date: May 2023 --> Aug 2023 | Trial primary completion date: May 2023 --> Aug 2023
- | NN1213 / Novo Nordisk
Trial completion date, Adherence: Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients (clinicaltrials.gov) - Apr 7, 2023
P=N/A, N=150, Completed, Sponsor: Assistance Publique Hopitaux De Marseille
Trial completion date: May 2023 --> Aug 2023 | Trial primary completion date: May 2023 --> Aug 2023 Trial completion date: Mar 2019 --> Nov 2022
- | NN1213 / Novo Nordisk
Phase classification: Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants (clinicaltrials.gov) - Mar 28, 2023
P4, N=60, Completed, Sponsor: State University of New York at Buffalo
Trial completion date: Mar 2019 --> Nov 2022 Phase classification: P=N/A --> P4
- | Trial completion, HEOR: REACH-ICD: REmote Web Assisted Care for Heart Failure Patients With Implantable Cardioverter Defibrillators (clinicaltrials.gov) - May 1, 2019
P=N/A, N=118, Completed, Sponsor: Wuerzburg University Hospital
Phase classification: P=N/A --> P4 Active, not recruiting --> Completed
- ||| Trial completion, Trial completion date, Trial primary completion date: Evaluation of a Multi-electrode Linear Type Catheter (D-1368-01-SI) (clinicaltrials.gov) - Apr 30, 2019
P=N/A, N=40, Completed, Sponsor: Biosense Webster, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Nov 2018 | Trial primary completion date: Mar 2019 --> Nov 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: S-ICD Brugada: Evaluation of Subcutaneous Implantable Cardiac Defibrillator in Brugada Patients (clinicaltrials.gov) - Apr 29, 2019
P=N/A, N=130, Completed, Sponsor: Nantes University Hospital
Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Nov 2018 | Trial primary completion date: Mar 2019 --> Nov 2018 Recruiting --> Completed | Trial completion date: Apr 2023 --> Apr 2019 | Trial primary completion date: Apr 2023 --> Apr 2019
- ||| NN1213 / Novo Nordisk
Trial completion: SULTAN: Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies (clinicaltrials.gov) - Apr 25, 2019
P=N/A, N=1013, Completed, Sponsor: Bayer
Recruiting --> Completed | Trial completion date: Apr 2023 --> Apr 2019 | Trial primary completion date: Apr 2023 --> Apr 2019 Active, not recruiting --> Completed
- ||| NN1213 / Novo Nordisk
Trial completion, Enrollment change: RPM-CIED: Remote Patient Management for Cardiac Implantable Electronic Devices (clinicaltrials.gov) - Apr 25, 2019
P=N/A, N=176, Completed, Sponsor: Ratika Parkash
Active, not recruiting --> Completed Recruiting --> Completed | N=275 --> 176
- | NN1213 / Novo Nordisk
Phase classification: IKONE: Assessment of the MRI Solution: KORA 100 and Beflex Pacing Leads System (clinicaltrials.gov) - Apr 23, 2019
P=N/A, N=33, Completed, Sponsor: MicroPort CRM
Recruiting --> Completed | N=275 --> 176 Phase classification: P3 --> P=N/A
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: 5A: LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke (clinicaltrials.gov) - Apr 23, 2019
P=N/A, N=474, Completed, Sponsor: The First Affiliated Hospital with Nanjing Medical University
Phase classification: P3 --> P=N/A Recruiting --> Completed | N=300 --> 474 | Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Dec 2018
- | Enrollment change, Trial termination, Surgery: Intravenous Lidocaine and Postoperative Outcomes After Cardiac Surgery (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=123, Terminated, Sponsor: The Cleveland Clinic
Recruiting --> Completed | N=300 --> 474 | Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Dec 2018 N=1294 --> 123 | Recruiting --> Terminated; Problem with enrollment
- | amiodarone / Generic mfg.
Trial completion, Enrollment change: Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD (clinicaltrials.gov) - Apr 20, 2019
P4, N=203, Completed, Sponsor: Texas Cardiac Arrhythmia Research Foundation
N=1294 --> 123 | Recruiting --> Terminated; Problem with enrollment Active, not recruiting --> Completed | N=120 --> 203
- |||| Trial termination: Ablate-VT: Therapy Cool Path Ablate VT (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=20, Terminated, Sponsor: Abbott Medical Devices
Active, not recruiting --> Completed | N=120 --> 203 Completed --> Terminated; Study data no longer needed
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Prospective Randomized Study on Clinical Effectiveness of Carvo-Tricuspid Isthmus Block in Patients With Paroxysmal Atrial Fibrillation (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=128, Completed, Sponsor: Yonsei University
Completed --> Terminated; Study data no longer needed Recruiting --> Completed | N=50 --> 128 | Trial completion date: Nov 2015 --> Apr 2018 | Trial primary completion date: Nov 2015 --> Apr 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Early Detection Of Atrial Fibrillation In Patients With Transient Ischemic Attack (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=150, Completed, Sponsor: University of Southern Denmark
Recruiting --> Completed | N=50 --> 128 | Trial completion date: Nov 2015 --> Apr 2018 | Trial primary completion date: Nov 2015 --> Apr 2018 Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Mar 2019 | Trial primary completion date: Nov 2017 --> Feb 2019
- | NN1213 / Novo Nordisk
Enrollment open, Trial completion date: Evaluation of Proper Radiofrequency Catheter Ablation Strategy for the Patients Who Were Changed to Paroxysmal Atrial Fibrillation From Persistent Atrial Fibrillation (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=120, Recruiting, Sponsor: Yonsei University
Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Mar 2019 | Trial primary completion date: Nov 2017 --> Feb 2019 Not yet recruiting --> Recruiting | Trial completion date: Feb 2024 --> Jun 2024
- | NN1213 / Novo Nordisk
Trial completion: Respiratory Motion Related Ablation Gap and Clinical Outcome After Catheter Ablation for Atrial Fibrillation (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=510, Completed, Sponsor: Yonsei University
Not yet recruiting --> Recruiting | Trial completion date: Feb 2024 --> Jun 2024 Not yet recruiting --> Completed
- | flecainide / Generic mfg.
Phase classification: Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=209, Completed, Sponsor: New York University School of Medicine
Not yet recruiting --> Completed Phase classification: P1/2 --> P=N/A
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Device-detected Paroxysmal Atrial Fibrillation (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=48, Completed, Sponsor: University of Birmingham
Phase classification: P1/2 --> P=N/A Recruiting --> Completed | N=80 --> 48 | Trial completion date: Jun 2016 --> Dec 2018 | Trial primary completion date: Jun 2016 --> Dec 2018
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Adherence: MEA Research: Impact of MayoExpertAdvisor on Provider Adherence (clinicaltrials.gov) - Apr 18, 2019
P=N/A, N=2248, Completed, Sponsor: Mayo Clinic
Recruiting --> Completed | N=80 --> 48 | Trial completion date: Jun 2016 --> Dec 2018 | Trial primary completion date: Jun 2016 --> Dec 2018 Enrolling by invitation --> Completed | N=327 --> 2248
- | Trial completion: VitC-AF: Vitamin C in Atrial Fibrillation Ablation (clinicaltrials.gov) - Apr 16, 2019
P2, N=20, Completed, Sponsor: Virginia Commonwealth University
Enrolling by invitation --> Completed | N=327 --> 2248 Active, not recruiting --> Completed
- | amiodarone / Generic mfg.
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock (clinicaltrials.gov) - Apr 2, 2019
P4, N=9, Terminated, Sponsor: The University of Texas Health Science Center at San Antonio
Active, not recruiting --> Completed N=200 --> 9 | Trial completion date: Mar 2019 --> Sep 2018 | Enrolling by invitation --> Terminated | Trial primary completion date: Mar 2019 --> Sep 2018; Investigator left institution
- | Trial completion, Trial completion date, Trial primary completion date: Evaluation of the Axonemal Dynein Heavy Chain 5 and Creatine Kinase Concentration in Cervical Fluid for Early Detection of the Ectopic Pregnancy (clinicaltrials.gov) - Mar 28, 2019
P=N/A, N=85, Completed, Sponsor: Ege University
N=200 --> 9 | Trial completion date: Mar 2019 --> Sep 2018 | Enrolling by invitation --> Terminated | Trial primary completion date: Mar 2019 --> Sep 2018; Investigator left institution Recruiting --> Completed | Trial completion date: Oct 2017 --> Nov 2018 | Trial primary completion date: Aug 2017 --> Jun 2018
- | Trial completion, Trial completion date, Trial primary completion date: The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Atrial Fibrillation (clinicaltrials.gov) - Mar 22, 2019
P=N/A, N=31, Completed, Sponsor: University of Kentucky
Recruiting --> Completed | Trial completion date: Oct 2017 --> Nov 2018 | Trial primary completion date: Aug 2017 --> Jun 2018 Recruiting --> Completed | Trial completion date: Jul 2019 --> Oct 2018 | Trial primary completion date: Jun 2019 --> Oct 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Comparison of High Versus Escalating Shocks in Cardioverting Atrial Fibrillation (clinicaltrials.gov) - Mar 22, 2019
P=N/A, N=276, Completed, Sponsor: University of Aarhus
Recruiting --> Completed | Trial completion date: Jul 2019 --> Oct 2018 | Trial primary completion date: Jun 2019 --> Oct 2018 Recruiting --> Completed | Trial completion date: Jun 2020 --> Mar 2019 | Trial primary completion date: May 2020 --> Mar 2019
- | NN1213 / Novo Nordisk
Biomarker, Trial completion date, Trial primary completion date: The Evaluation for Prognostic Factors After Catheter Ablation of Atrial Fibrillation: Cohort Study (clinicaltrials.gov) - Mar 18, 2019
P=N/A, N=3100, Recruiting, Sponsor: Yonsei University
Recruiting --> Completed | Trial completion date: Jun 2020 --> Mar 2019 | Trial primary completion date: May 2020 --> Mar 2019 Trial completion date: Apr 2024 --> Feb 2029 | Trial primary completion date: Apr 2024 --> Feb 2029
- | NN1213 / Novo Nordisk
Trial completion: Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Prospective Randomized Study (clinicaltrials.gov) - Mar 18, 2019
P=N/A, N=40, Completed, Sponsor: Yonsei University
Trial completion date: Apr 2024 --> Feb 2029 | Trial primary completion date: Apr 2024 --> Feb 2029 Recruiting --> Completed
- NN1213 / Novo Nordisk
Enrollment change, Trial completion date, Trial termination: CoolLoop PAF: CoolLoop Paroxysmal Atrial Fibrillation (clinicaltrials.gov) - Mar 15, 2019
P=N/A, N=20, Terminated, Sponsor: AFreeze GmbH
Recruiting --> Completed N=112 --> 20 | Trial completion date: Oct 2019 --> Feb 2019 | Active, not recruiting --> Terminated; insufficient patient recruitment
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Adherence: Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients (clinicaltrials.gov) - Mar 13, 2019
P=N/A, N=150, Completed, Sponsor: Assistance Publique Hopitaux De Marseille
N=112 --> 20 | Trial completion date: Oct 2019 --> Feb 2019 | Active, not recruiting --> Terminated; insufficient patient recruitment Not yet recruiting --> Completed | Trial completion date: Jun 2018 --> Mar 2019
- | NN1213 / Novo Nordisk
Trial completion: FAST Mapping During Atrial Fibrillation (clinicaltrials.gov) - Mar 6, 2019
P=N/A, N=80, Completed, Sponsor: University Health Network, Toronto
Not yet recruiting --> Completed | Trial completion date: Jun 2018 --> Mar 2019 Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Reverse Prediction of Ion Channel Remodeling in Patients With Atrial Fibrillation Utilizing Monophasic Action Potential and Mathematical Modeling (clinicaltrials.gov) - Feb 27, 2019
P=N/A, N=50, Completed, Sponsor: Yonsei University
Recruiting --> Completed Recruiting --> Completed | Trial completion date: Oct 2015 --> Mar 2017 | Trial primary completion date: Oct 2015 --> Mar 2017
- ||| apixaban / Generic mfg.
Trial completion, Trial primary completion date: APAF: Apixaban in Atrial Fibrillation Registry (clinicaltrials.gov) - Feb 27, 2019
P=N/A, N=5015, Completed, Sponsor: IHF GmbH - Institut f
Recruiting --> Completed | Trial completion date: Oct 2015 --> Mar 2017 | Trial primary completion date: Oct 2015 --> Mar 2017 Active, not recruiting --> Completed | Trial primary completion date: Jan 2017 --> Aug 2018
- | NN1213 / Novo Nordisk
Trial completion: Comparison of Single Groin and Single Trans-septal Puncture and Conventional Bilateral Groin Puncture and Double Trans-septal Puncture in Catheter Ablation for Atrial Fibrillation (clinicaltrials.gov) - Feb 26, 2019
P=N/A, N=105, Completed, Sponsor: Yonsei University
Active, not recruiting --> Completed | Trial primary completion date: Jan 2017 --> Aug 2018 Recruiting --> Completed
- | NN1213 / Novo Nordisk
Phase classification: Premature Ventricular Contractions (PVCs) and Blood Pressure Control (clinicaltrials.gov) - Feb 22, 2019
P2, N=8, Terminated, Sponsor: University of Wisconsin, Madison
Recruiting --> Completed Phase classification: P=N/A --> P2
- | NN1213 / Novo Nordisk, Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Trial completion, Surgery: Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery (clinicaltrials.gov) - Feb 22, 2019
P1/2, N=130, Completed, Sponsor: Joseph Mathew, M.D.
Phase classification: P=N/A --> P2 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: AVATAR-AF: Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation (clinicaltrials.gov) - Feb 21, 2019
P=N/A, N=300, Completed, Sponsor: Imperial College London
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Physiotherapist Led Group-exercise Compared Physical Activity on Prescription, a 3 Months Follow-up (clinicaltrials.gov) - Feb 20, 2019
P=N/A, N=87, Completed, Sponsor: G
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Dec 2017 --> Aug 2017 | Trial primary completion date: Dec 2017 --> Aug 2017
- ||| Trial completion, Trial completion date: 2016-IMR: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter II (clinicaltrials.gov) - Feb 19, 2019
P=N/A, N=36, Completed, Sponsor: University of Leipzig
Recruiting --> Completed | Trial completion date: Dec 2017 --> Aug 2017 | Trial primary completion date: Dec 2017 --> Aug 2017 Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Jan 2019
- | Trial completion, Enrollment change: A.Fib Emergency Department Study Atrial Fibrillation (clinicaltrials.gov) - Feb 15, 2019
P=N/A, N=297, Completed, Sponsor: Queen's University
Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Jan 2019 Recruiting --> Completed | N=778 --> 297
- || Trial completion date, Trial primary completion date: DF4 Connector System Post-Approval Study (clinicaltrials.gov) - Feb 12, 2019
P=N/A, N=1778, Active, not recruiting, Sponsor: Medtronic
Recruiting --> Completed | N=778 --> 297 Trial completion date: Jan 2019 --> May 2019 | Trial primary completion date: Jan 2019 --> May 2019
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Assessment of Thrombotic Status in Patients at Risk of Cardiovascular Thrombosis (clinicaltrials.gov) - Feb 8, 2019
P=N/A, N=140, Completed, Sponsor: East and North Hertfordshire NHS Trust
Trial completion date: Jan 2019 --> May 2019 | Trial primary completion date: Jan 2019 --> May 2019 Recruiting --> Completed | Trial completion date: Mar 2018 --> Sep 2018 | Trial primary completion date: Mar 2018 --> Sep 2018
- | Trial completion, Enrollment change, Trial primary completion date, Surgery: Antithrombotic Therapy in Patients Undergoing CIED Surgery - HEMATOMA NO MORE Registry (clinicaltrials.gov) - Feb 8, 2019
P=N/A, N=1450, Completed, Sponsor: Azienda Ospedaliera Universitaria Senese
Recruiting --> Completed | Trial completion date: Mar 2018 --> Sep 2018 | Trial primary completion date: Mar 2018 --> Sep 2018 Recruiting --> Completed | N=1000 --> 1450 | Trial primary completion date: Dec 2017 --> Sep 2017
- | Phase classification: SENSE-AF: OptiSense (clinicaltrials.gov) - Feb 4, 2019
P=N/A, N=50, Completed, Sponsor: Abbott Medical Devices
Recruiting --> Completed | N=1000 --> 1450 | Trial primary completion date: Dec 2017 --> Sep 2017 Phase classification: P4 --> P=N/A
- ||| Trial completion, Enrollment change, Trial completion date: ENHANCE-Efficacy of the Presence of Right Ventricular Apical Pacing Induced Ventricular Dyssynchrony as a Guiding Parameter for Biventricular Pacing in Patients With Bradycardia and Normal Ejection Fraction (clinicaltrials.gov) - Feb 4, 2019
P=N/A, N=98, Completed, Sponsor: Abbott Medical Devices
Phase classification: P4 --> P=N/A Active, not recruiting --> Completed | N=177 --> 98 | Trial completion date: Jul 2016 --> Apr 2016
- | NN1213 / Novo Nordisk
Trial completion: POP-ECG-HF-AF: A Study of Prolonged Electrocardiographic Monitoring in Patients With Heart Failure in Sinus Rhythm or Atrial Fibrillation (clinicaltrials.gov) - Feb 4, 2019
P=N/A, N=100, Completed, Sponsor: Imperial College London
Active, not recruiting --> Completed | N=177 --> 98 | Trial completion date: Jul 2016 --> Apr 2016 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Enrollment change: S-ICD Brugada: Evaluation of Subcutaneous Implantable Cardiac Defibrillator in Brugada Patients (clinicaltrials.gov) - Jan 31, 2019
P=N/A, N=130, Recruiting, Sponsor: Nantes University Hospital
Active, not recruiting --> Completed N=200 --> 130
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: FLS-ICE-R: Intracardiac Echocardiography in Atrial Flutter Ablation (clinicaltrials.gov) - Jan 31, 2019
P3, N=79, Completed, Sponsor: Charles University, Czech Republic
N=200 --> 130 Recruiting --> Completed | Trial completion date: Dec 2016 --> Apr 2017 | Trial primary completion date: Dec 2016 --> Apr 2017
- | NN1213 / Novo Nordisk
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Safety and Efficacy of Left Atrial Appendage Closure Versus Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due to Complex Coronary Artery Disease (clinicaltrials.gov) - Jan 28, 2019
P4, N=9, Terminated, Sponsor: Yonsei University
Recruiting --> Completed | Trial completion date: Dec 2016 --> Apr 2017 | Trial primary completion date: Dec 2016 --> Apr 2017 N=670 --> 9 | Trial completion date: Nov 2022 --> Jun 2017 | Not yet recruiting --> Terminated | Trial primary completion date: Nov 2020 --> Jun 2017; The number of patients registered for the study was low and it was expected to be difficult to derive the study results.